Carina Venter, PhD, RD, allergy specialist dietitian and associate professor in pediatric allergy and immunology at Children's Hospital Colorado and the University of Colorado, discusses the gut microbiome’s complex relationship with our immune system and diet diversity’s potential role in allergic disease and food allergy–related outcomes.
Carina Venter, PhD, RD, allergy specialist dietitian and associate professor in pediatric allergy and immunology at Children's Hospital Colorado and the University of Colorado, discusses the gut microbiome’s complex relationship with our immune system and diet diversity’s potential role in allergic disease and food allergy–related outcomes.
She presented “Can the Microbiome be Manipulated to Prevent Food Allergy” during the symposium, “Solving the Puzzle of Food Allergy Prevention,” at this year’s American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Transcript
How does the gut microbiome contribute to the immune system’s reaction to certain allergens?
I think it's a very complex situation, which I'm trying to explain in a few simple sentences. In short, we know that the gut microbiome, particularly a more diverse gut microbiome, produces certain short-chain fatty acids; that's really been the aspects that I've been looking at. Clearly, there's many other metabolites that are produced by the gut microbiome. But in terms of the short-chain fatty acids, it seems that for now, butyrate is the most important fatty acid. Butyrate sort of has crosstalk with the immune system. It upregulates, or increases, the function of the T regulatory cells. The T regulatory cells just try and calm everything down again—if I can put it in simple terms. Really, in short, if we have a healthier or more diverse gut microbiome, which can help us to make more butyrate, perhaps we'll find that our immune system will be more tolerant to all the food allergens that we put into our gut.
How does the microbiome affect different types of atopic diseases?
That's a really good question: whether diet diversity affects all allergic disease outcomes in the same way. I’m first author of an [European Academy of Allergy and Clinical Immunology] EAACI position statement, where we looked at diversity in infancy vs asthma, allergic rhinitis, eczema, and food allergy outcomes. At this point in time, we see the biggest signal between diet diversity and food allergy. The data were a little bit more conflicting, particularly for eczema, where almost a certain number of papers indicated that increased diet diversity may prevent eczema later on in childhood vs no effect on eczema prevention. We even had a few papers that showed increased diet diversity was associated with increased eczema or atopic dermatitis outcomes.
I looked at my own data then to see, when we look a little bit more mechanistic and at IgE production, what happens, and clearly we showed that increased diet diversity by 6 months was associated with reduced sensitization to food allergens. But there was no effect seen on the aeroallergens. So perhaps there is some sort of specific interaction between diet diversity, its effect on the gut microbiome, and food allergen sensitization and food allergy outcomes specifically.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More